CILK1
Basic information
Region (hg38): 6:53001279-53061824
Previous symbols: [ "ICK" ]
Links
Phenotypes
GenCC
Source:
- endocrine-cerebro-osteodysplasia syndrome (Moderate), mode of inheritance: AR
- juvenile myoclonic epilepsy (Supportive), mode of inheritance: AD
- endocrine-cerebro-osteodysplasia syndrome (Supportive), mode of inheritance: AR
- endocrine-cerebro-osteodysplasia syndrome (Strong), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Epilepsy, juvenile myoclonic, susceptibility to, 10; Endocrine-cerebroosteodysplasia | AD/AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Craniofacial; Endocrine; Genitourinary; Musculoskeletal; Neurologic | 19185282; 29539279 |
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CILK1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 44 | 49 | ||||
missense | 76 | 84 | ||||
nonsense | 5 | |||||
start loss | 0 | |||||
frameshift | 1 | |||||
inframe indel | 1 | |||||
splice donor/acceptor (+/-2bp) | 2 | |||||
splice region | 6 | 7 | 1 | 14 | ||
non coding | 11 | 12 | 23 | |||
Total | 0 | 1 | 85 | 62 | 17 |
Variants in CILK1
This is a list of pathogenic ClinVar variants found in the CILK1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
6-53005154-G-A | Epilepsy, juvenile myoclonic, susceptibility to, 10 | Uncertain significance (Jul 06, 2022) | ||
6-53005156-C-G | not specified | Uncertain significance (Jul 22, 2022) | ||
6-53005156-C-T | not specified | Uncertain significance (May 03, 2024) | ||
6-53005163-C-T | not specified | Uncertain significance (Mar 15, 2024) | ||
6-53005178-A-C | Uncertain significance (Feb 10, 2022) | |||
6-53005186-C-T | not specified | Likely benign (May 01, 2024) | ||
6-53005197-T-C | Likely benign (Aug 03, 2023) | |||
6-53005200-C-G | Uncertain significance (May 08, 2021) | |||
6-53005205-C-T | Epilepsy, juvenile myoclonic, susceptibility to, 10 | Uncertain significance (Jun 20, 2022) | ||
6-53005218-T-C | Likely benign (Feb 14, 2023) | |||
6-53005220-G-A | CILK1-related disorder | Uncertain significance (Mar 29, 2024) | ||
6-53005246-T-C | not specified | Uncertain significance (Sep 21, 2023) | ||
6-53005249-G-C | Uncertain significance (Oct 22, 2022) | |||
6-53005259-A-T | not specified | Uncertain significance (Feb 09, 2024) | ||
6-53005266-C-T | Likely benign (Nov 16, 2023) | |||
6-53005296-G-A | Likely benign (Jul 05, 2022) | |||
6-53005314-A-G | Likely benign (Apr 07, 2022) | |||
6-53005376-G-C | Benign (May 26, 2021) | |||
6-53005522-A-C | Benign (May 12, 2021) | |||
6-53006356-A-G | Uncertain significance (Aug 28, 2021) | |||
6-53006357-T-C | CILK1-related disorder • not specified | Conflicting classifications of pathogenicity (Jul 18, 2022) | ||
6-53006357-T-G | Uncertain significance (Jan 19, 2021) | |||
6-53006366-C-T | not specified | Likely benign (Aug 12, 2022) | ||
6-53006372-C-A | not specified | Uncertain significance (Jun 28, 2024) | ||
6-53006389-G-C | Seizure | Uncertain significance (Mar 24, 2020) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
CILK1 | protein_coding | protein_coding | ENST00000356971 | 13 | 60524 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0000134 | 1.00 | 125712 | 0 | 36 | 125748 | 0.000143 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.24 | 276 | 340 | 0.811 | 0.0000183 | 4123 |
Missense in Polyphen | 76 | 106.5 | 0.71359 | 1297 | ||
Synonymous | -0.500 | 131 | 124 | 1.06 | 0.00000666 | 1237 |
Loss of Function | 3.42 | 15 | 37.7 | 0.398 | 0.00000248 | 388 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000568 | 0.000568 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000435 | 0.000435 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000970 | 0.0000967 |
Middle Eastern | 0.000435 | 0.000435 |
South Asian | 0.0000327 | 0.0000327 |
Other | 0.000326 | 0.000326 |
dbNSFP
Source:
- Function
- FUNCTION: Required for ciliogenesis (PubMed:24797473). Phosphorylates KIF3A (By similarity). Involved in the control of ciliary length (PubMed:24853502). Regulates the ciliary localization of SHH pathway components as well as the localization of IFT components at ciliary tips (By similarity). May play a key role in the development of multiple organ systems and particularly in cardiac development (By similarity). Regulates intraflagellar transport (IFT) speed and negatively regulates cilium length in a cAMP and mTORC1 signaling-dependent manner and this regulation requires its kinase activity (By similarity). {ECO:0000250|UniProtKB:Q62726, ECO:0000250|UniProtKB:Q9JKV2, ECO:0000269|PubMed:24797473, ECO:0000269|PubMed:24853502}.;
- Disease
- DISEASE: Endocrine-cerebroosteodysplasia (ECO) [MIM:612651]: Previously unidentified neonatal lethal recessive disorder with multiple anomalies involving the endocrine, cerebral, and skeletal systems. {ECO:0000269|PubMed:19185282, ECO:0000269|PubMed:24797473, ECO:0000269|PubMed:24853502, ECO:0000269|PubMed:29539279}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Juvenile myoclonic epilepsy 10 (EJM10) [MIM:617924]: A form of juvenile myoclonic epilepsy, a subtype of idiopathic generalized epilepsy generally characterized by afebrile seizures with onset in adolescence (rather than in childhood) and myoclonic jerks, which usually occur after awakening and are triggered by sleep deprivation and fatigue. EJM10 is an autosomal dominant seizure disorder with variable manifestations, even within families. Affected individuals have febrile, myoclonic, tonic- clonic, or absence seizures, although several seizure types can occur in the same individual. Some patients have onset of seizures in the first years of life. {ECO:0000269|PubMed:29539279}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.0861
Intolerance Scores
- loftool
- 0.665
- rvis_EVS
- -0.2
- rvis_percentile_EVS
- 39.11
Haploinsufficiency Scores
- pHI
- 0.225
- hipred
- Y
- hipred_score
- 0.756
- ghis
- 0.518
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.654
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Ick
- Phenotype
- growth/size/body region phenotype; homeostasis/metabolism phenotype; cellular phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); craniofacial phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); skeleton phenotype; renal/urinary system phenotype; digestive/alimentary phenotype; limbs/digits/tail phenotype;
Gene ontology
- Biological process
- protein phosphorylation;signal transduction;multicellular organism development;regulation of gene expression;intracellular signal transduction;intraciliary anterograde transport;intraciliary retrograde transport;intraciliary transport;cilium assembly
- Cellular component
- fibrillar center;nucleus;cytoplasm;cytosol;cilium;ciliary basal body;ciliary tip;ciliary base
- Molecular function
- magnesium ion binding;protein kinase activity;protein serine/threonine kinase activity;protein binding;ATP binding